These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32413997)

  • 1. Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction.
    Maki S; Kato I; Enomoto N; Takakura S; Nii M; Tanaka K; Tanaka H; Hori S; Matsuda K; Ueda Y; Sawada H; Hirayama M; Sudo A; Ikeda T
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32413997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental assessment of VLBW infants at 18 months of age: A comparison study between KSPD and Bayley III.
    Kono Y; Yonemoto N; Kusuda S; Hirano S; Iwata O; Tanaka K; Nakazawa J
    Brain Dev; 2016 Apr; 38(4):377-85. PubMed ID: 26542468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longer body length and larger head circumference at term significantly influences a better subsequent psychomotor development in very-low-birth-weight infants.
    Egashira T; Hashimoto M; Shiraishi TA; Shichijo A; Egashira M; Mizukami T; Takayanagi T
    Brain Dev; 2019 Apr; 41(4):313-319. PubMed ID: 30527841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Kyoto Scale of Psychological Development 2001 with the parent-rated Kinder Infant Development Scale (KIDS).
    Aoki S; Hashimoto K; Ikeda N; Takekoh M; Fujiwara T; Morisaki N; Mezawa H; Tachibana Y; Ohya Y
    Brain Dev; 2016 May; 38(5):481-90. PubMed ID: 26612486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features of Neurodevelopmental Outcomes in Children with Preterm Severe Fetal Growth Restriction: A Retrospective Observational Study.
    Motoki T; Chigusa Y; Tomotaki S; Kawamura Y; Taki M; Yamaguchi K; Mandai M; Mogami H
    JMA J; 2022 Jul; 5(3):341-348. PubMed ID: 35992293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely preterm infants small for gestational age are at risk for motor impairment at 3 years corrected age.
    Kato T; Mandai T; Iwatani S; Koda T; Nagasaka M; Fujita K; Kurokawa D; Yamana K; Nishida K; Taniguchi-Ikeda M; Tanimura K; Deguchi M; Yamada H; Iijima K; Morioka I
    Brain Dev; 2016 Feb; 38(2):188-95. PubMed ID: 26265090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison.
    Gutbrod T; Wolke D; Soehne B; Ohrt B; Riegel K
    Arch Dis Child Fetal Neonatal Ed; 2000 May; 82(3):F208-14. PubMed ID: 10794788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
    Umekawa T; Maki S; Kubo M; Tanaka H; Nii M; Tanaka K; Osato K; Kamimoto Y; Tamaru S; Ogura T; Nishimura Y; Kodera M; Minamide C; Nishikawa M; Endoh M; Kimura T; Kotani T; Nakamura M; Sekizawa A; Ikeda T;
    BMJ Open; 2018 Oct; 8(10):e020948. PubMed ID: 30381311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of very low birth weight infants to age 20 years.
    Hack M; Schluchter M; Cartar L; Rahman M; Cuttler L; Borawski E
    Pediatrics; 2003 Jul; 112(1 Pt 1):e30-8. PubMed ID: 12837903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity.
    Arima M; Akiyama M; Fujiwara K; Mori Y; Inoue H; Seki E; Nakama T; Tsukamoto S; Ochiai M; Ohga S; Sonoda KH
    PLoS One; 2020; 15(3):e0230678. PubMed ID: 32196539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes.
    Kubo M; Umekawa T; Maekawa Y; Tanaka H; Nii M; Murabayashi N; Osato K; Kamimoto Y; Ikeda T
    J Obstet Gynaecol Res; 2017 Feb; 43(2):291-297. PubMed ID: 27987345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial.
    Pels A; Knaven OC; Wijnberg-Williams BJ; Eijsermans MJC; Mulder-de Tollenaer SM; Aarnoudse-Moens CSH; Koopman-Esseboom C; van Eyck J; Derks JB; Ganzevoort W; van Wassenaer-Leemhuis AG
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():63-70. PubMed ID: 30660941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth factor as a predictor of the efficacy of tadalafil treatment for fetal growth restriction.
    Kubo-Kaneda M; Tanaka H; Maki S; Nii M; Umekawa T; Osato K; Kamimoto Y; Kondo E; Ikeda T
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2879-2882. PubMed ID: 29580120
    [No Abstract]   [Full Text] [Related]  

  • 15. [A follow-up on first-year growth and development of 61 very low birth weight preterm infants].
    Deng Y; Xiong F; Wu MM; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Jun; 18(6):482-7. PubMed ID: 27324533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial.
    Maki S; Tanaka H; Tsuji M; Furuhashi F; Magawa S; Kaneda MK; Nii M; Tanaka K; Kondo E; Tamaru S; Ogura T; Nishimura Y; Endoh M; Kimura T; Kotani T; Sekizawa A; Ikeda T
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31208060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
    Tachibana R; Umekawa T; Yoshikawa K; Owa T; Magawa S; Furuhashi F; Tsuji M; Maki S; Shimada K; Kaneda MK; Nii M; Tanaka H; Tanaka K; Kamimoto Y; Kondo E; Kato I; Ikemura K; Okuda M; Ma N; Miyoshi T; Hosoda H; Endoh M; Kimura T; Ikeda T
    Sci Rep; 2019 Jan; 9(1):234. PubMed ID: 30659198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and intensive nutritional strategy combining parenteral and enteral feeding promotes neurodevelopment and growth at 18months of corrected age and 3years of age in extremely low birth weight infants.
    Ohnishi S; Ichiba H; Tanaka Y; Harada S; Matsumura H; Kan A; Asada Y; Shintaku H
    Early Hum Dev; 2016 Sep; 100():35-41. PubMed ID: 27391871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth of very-low-birth-weight infants at 5 years old in Taiwan.
    Wang PW; Fang LJ; Tsou KI;
    Pediatr Neonatol; 2014 Apr; 55(2):114-9. PubMed ID: 24126010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head circumference and long-term outcome in small-for-gestational age infants.
    Ochiai M; Nakayama H; Sato K; Iida K; Hikino S; Ohga S; Tsukimori K; Wake N; Masumoto K; Taguchi T; Hara T
    J Perinat Med; 2008; 36(4):341-7. PubMed ID: 18598125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.